Abstract
5/2007
vol. 10
Asthma treatment with budesonide/formoterol in a single inhaler (Symbicort - Astra Zeneca) adjustable to needs (maintenance and reliever medication)
Przew Lek 2007; 5: 87-93
Online publish date: 2007/09/07
Budesonide/formoterol – Symbicort (Astra Zeneca), a combination of budesonide, an inhaled corticosteroid providing an anti-inflammatory effect, and formoterol, a unique rapid and long-acting bronchodilator, which is delivered in one inhaler. The new treatment approach for asthma budesonide/formoterol maintenance and reliever therapy (SMART) is more effective than fixed doses of budesonide/formoterol or fluticasone/salmeterol. With adjustable maintenance dosing where patients step up or down their medication. Symbicort improves asthma control and quality of life, and reduces the number of a exacerbations at a smaller total dose of inhaled glucocorticosteroids in comparison with fixed dosing.
Keywords
asthma, budesonide/formoterol, maintence therapy, on demand
Integrated with